Sector
PharmaceuticalsOpen
₹2.7Prev. Close
₹2.85Turnover(Lac.)
₹0.03Day's High
₹2.9Day's Low
₹2.752 Week's High
₹052 Week's Low
₹0Book Value
₹-290.46Face Value
₹10Mkt Cap (₹ Cr.)
8.65P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Equity Capital | 64.37 | 64.37 | 64.37 | 64.37 |
Preference Capital | 76.71 | 76.71 | 76.71 | 76.71 |
Reserves | -747.57 | -626 | -511.62 | -172.14 |
Net Worth | -606.49 | -484.92 | -370.54 | -31.06 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 12.16 | 31.87 | 32.95 | 52.2 |
yoy growth (%) | -61.82 | -3.27 | -36.88 | -64.9 |
Raw materials | -5.66 | -6.32 | -6.76 | -26.02 |
As % of sales | 46.54 | 19.83 | 20.51 | 49.84 |
Employee costs | -14.51 | -19.2 | -16.69 | -15.11 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -154.47 | -141.73 | -119.4 | -125.06 |
Depreciation | -17.32 | -17.34 | -18.56 | -19.1 |
Tax paid | 32.75 | 27.66 | 23.31 | 11.07 |
Working capital | -137.33 | -242.01 | -101.49 | -144.23 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -61.82 | -3.27 | -36.88 | -64.9 |
Op profit growth | -19.83 | -7.3 | -54.16 | -27.09 |
EBIT growth | -8.63 | -3.88 | -35.33 | -18.27 |
Net profit growth | 6.69 | 18.7 | -15.77 | 5.15 |
| Particulars (Rupees in Crores.) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|---|
Gross Sales | 8.5 | 12.17 | 31.87 | 32.03 | 217.11 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 8.5 | 12.17 | 31.87 | 32.03 | 217.11 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 52.28 | 0.06 | 0.25 | 1.44 | 1.59 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,710.5 | 96 | 4,10,466.23 | 2,000.46 | 0.94 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,676.5 | 80.29 | 1,77,298.5 | 667 | 0.45 | 2,536 | 561.08 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,768.1 | 67.4 | 1,27,532.36 | 551 | 0.16 | 2,567 | 224.34 |
Cipla Ltd CIPLA | 1,574 | 24.61 | 1,27,140.04 | 1,303.13 | 1.02 | 4,501.66 | 397.39 |
Dr Reddys Laboratories Ltd DRREDDY | 1,299.8 | 15.74 | 1,08,499.8 | 2,961.2 | 0.61 | 7,788.7 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman
Manoharlal Gupta
Whole-time Director
Govind Das Garg
Independent Director
Dharam Pal Khanna
Independent Director
Dilip Kumar Sinha
Non Executive Director
Anil Mittal
Independent Director
Manish Verma
Managing Director & CFO
Vinod Kumar Gupta
Independent Director
Deepali Garhewal
Independent Director
Chhaya Gupta
340 Laxmi Plaza Laxmi Indl Est,
New Link Road Andheri (West),
Maharashtra - 400053
Tel: 91-022-61725900-1
Website: http://www.pdindia.com
Email: pdpl_mumbai@pdindia.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Parenteral Drugs (India) Limited was incorporated in 1983 as a private limited company. In 1989, the Company established their first unit to manufacture I V Fluids in Polypropylene containers with a c...
Read More
Reports by Parenteral Drugs India Ltd
What is the Parenteral Drugs India Ltd share price today?
What is the Market Cap of Parenteral Drugs India Ltd?
What is the PE and PB ratio of Parenteral Drugs India Ltd?
What is the 52 Week High and Low of Parenteral Drugs India Ltd?
What is the CAGR of Parenteral Drugs India Ltd?
What is the shareholding pattern of Parenteral Drugs India Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.